ArticleCureus2026
Steroid Cell Tumor of the Ovary Presenting With Postmenopausal Bleeding and Hyperandrogenism: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Steroid cell tumors of the ovary are rare, often hormonally active neoplasms that may present with features of hyperandrogenism. We report the case of a 60-year-old woman who initially presented with postmenopausal bleeding and a reassuringly thin endometrium, with symptoms attributed to hormone replacement therapy. Over time, the development of progressive hirsutism and persistently elevated serum testosterone levels prompted further investigation. Multidisciplinary team involvement, including endocrinology input, was pivotal in identifying a suspected androgen-secreting ovarian tumor and guiding definitive management. Bilateral salpingo-oophorectomy confirmed a steroid cell tumor of the left ovary, International Federation of Gynecology and Obstetrics (FIGO) stage IA, with complete biochemical and clinical resolution. This case highlights the importance of reassessing postmenopausal patients with evolving hyperandrogenic features despite initially reassuring findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.